Company Website: http://www.bms.com
NEW YORK -- (Business Wire)

Bristol-Myers Squibb Company (NYSE: BMY) will take part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference on Thursday, May 31, 2012, in New York. Lamberto Andreotti, chief executive officer, will answer questions about the company at 9 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contacts:

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

Source: Bristol-Myers Squibb Company